Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Buy

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Sell

C

NanoVibronix, Inc. Common Stock (NAOV)

Orthopedic, Prosthetic & Surgical Appliances & Supplies

https://www.nanovibronix.com

NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low frequency, low intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.

525 EXECUTIVE BLVD
ELMSFORD, NY

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

04/24/2015

Market Cap

1,714,046

Shares Outstanding

2,049,999

Weighted SO

2,046,354

Total Employees

N/A

Upcoming Earnings

N/A

Beta

1.5380

Last Div

0.0000

Range

0.52-4.23

Chg

0.0155

Avg Vol

37666

Mkt Cap

1714046

Exch

NASDAQ

Country

US

Phone

914 233 3004

DCF Diff

0.8851

DCF

-0.0661

Div Yield

0.0000

P/S

0.5082

EV Multiple

0.1235

P/FV

603.3255

Div Yield %

0.0000

P/E

-608.6817

PEG

-15.0373

Payout

0.0000

Current Ratio

2.1072

Quick Ratio

1.1561

Cash Ratio

0.8490

DSO

32.0308

DIO

742.5230

Op Cycle

774.5538

DPO

0.0000

CCC

774.5538

Gross Margin

0.6457

Op Margin

-0.7750

Pretax Margin

-0.8316

Net Margin

-0.8349

Eff Tax Rate

0.0011

ROA

-0.4944

ROE

-0.7498

ROCE

-0.8325

NI/EBT

1.0039

EBT/EBIT

1.0731

EBIT/Rev

-0.7750

Debt Ratio

0.0233

D/E

0.0468

LT Debt/Cap

0.0304

Total Debt/Cap

0.0447

Int Coverage

37.3429

CF/Debt

-13.1729

Equity Multi

2.0049

Rec Turnover

11.3953

Pay Turnover

0.0000

Inv Turnover

0.4916

FA Turnover

23.7535

Asset Turnover

0.5922

OCF/Share

-0.0006

FCF/Share

-0.0006

Cash/Share

0.0008

OCF/Sales

-0.5194

FCF/OCF

1.0006

CF Coverage

-13.1729

ST Coverage

-39.8182

CapEx Coverage

-1752.0000

Div&CapEx Cov

-1752.0000

P/BV

603.3255

P/B

603.3255

P/S

0.5082

P/E

-608.6817

P/FCF

-0.9778

P/OCF

-978.3377

P/CF

-978.3377

PEG

-15.0373

P/S

0.5082

EV Multiple

0.1235

P/FV

603.3255

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation